224 related articles for article (PubMed ID: 27383411)
21. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
[TBL] [Abstract][Full Text] [Related]
23. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
25. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.
Fisher R; Horswell S; Rowan A; Salm MP; de Bruin EC; Gulati S; McGranahan N; Stares M; Gerlinger M; Varela I; Crockford A; Favero F; Quidville V; André F; Navas C; Grönroos E; Nicol D; Hazell S; Hrouda D; O'Brien T; Matthews N; Phillimore B; Begum S; Rabinowitz A; Biggs J; Bates PA; McDonald NQ; Stamp G; Spencer-Dene B; Hsieh JJ; Xu J; Pickering L; Gore M; Larkin J; Swanton C
Genome Biol; 2014 Aug; 15(8):433. PubMed ID: 25159823
[TBL] [Abstract][Full Text] [Related]
26. Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma.
Tabata M; Sato Y; Kogure Y; McClure MB; Oshikawa-Kumade Y; Saito Y; Shingaki S; Ito Y; Yuasa M; Koya J; Yoshida K; Kohno T; Miyama Y; Morikawa T; Chiba K; Okada A; Ogawa S; Ushiku T; Shiraishi Y; Kume H; Kataoka K
Cell Rep; 2023 Jul; 42(7):112736. PubMed ID: 37405915
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis as a tool in the differential diagnosis of VHL disease-related tumors.
Gijtenbeek J; Jacobs B; Boots-Sprenger S; Bonne A; Lenders J; Küsters B; Wesseling P; Jeuken J
Diagn Mol Pathol; 2005 Jun; 14(2):115-20. PubMed ID: 15905696
[TBL] [Abstract][Full Text] [Related]
28. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
Nickerson ML; Jaeger E; Shi Y; Durocher JA; Mahurkar S; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Mukeria A; Holcatova I; Schmidt LS; Toro JR; Karami S; Hung R; Gerard GF; Linehan WM; Merino M; Zbar B; Boffetta P; Brennan P; Rothman N; Chow WH; Waldman FM; Moore LE
Clin Cancer Res; 2008 Aug; 14(15):4726-34. PubMed ID: 18676741
[TBL] [Abstract][Full Text] [Related]
29. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
30. Distinct patterns of chromosomal losses in clinically synchronous and asynchronous bilateral renal cell carcinoma.
Kito H; Suzuki H; Igarashi T; Tobe T; Mizoguchi K; Kamiya N; Ichikawa T; Ito H
J Urol; 2002 Dec; 168(6):2637-40. PubMed ID: 12442000
[TBL] [Abstract][Full Text] [Related]
31. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
32. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
33. Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.
Vocke CD; Ricketts CJ; Metwalli AR; Pinto PA; Gautam R; Raffeld M; Merino MJ; Ball MW; Linehan WM
Urology; 2022 Jul; 165():170-177. PubMed ID: 35469800
[TBL] [Abstract][Full Text] [Related]
34. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
Ma X; Yang K; Lindblad P; Egevad L; Hemminki K
Oncogene; 2001 Aug; 20(38):5393-400. PubMed ID: 11536052
[TBL] [Abstract][Full Text] [Related]
35. [Localization of point mutations in the coding part of the VHL gene in clear cell renal cancer].
Mikhaĭlenko DS; Grigor'eva MV; Rusakov IG; Kurynin RV; Popov AM; Peters MV; Matveev VB; Iakovlev ES; Nosov DA; Liubchenko LN; Tiuliandin SA; Strel'nikov VV; Zaletaev DV
Mol Biol (Mosk); 2012; 46(1):71-81. PubMed ID: 22642103
[TBL] [Abstract][Full Text] [Related]
36. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
Zhang YT; Chen N; Zeng H; Zhou Q
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
[No Abstract] [Full Text] [Related]
37. Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.
Mochida J; Esumi M; Kitajima A; Okada K
J Urol; 2008 Aug; 180(2):724-8. PubMed ID: 18554638
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
[TBL] [Abstract][Full Text] [Related]
40. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
